Medicus Pharma Ltd.

NASDAQ: MDCXW · Real-Time Price · USD
0.65
0.00 (0.00%)
At close: Aug 15, 2025, 3:38 PM
0.65
0.02%
After-hours: Aug 15, 2025, 04:00 PM EDT

Medicus Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q3 2022
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Sep 30, 2022
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
52.56K 78.48K 78.48K 51.95K 25.92K n/a n/a n/a
Gross Profit
-52.56K -78.48K -78.48K -51.95K -25.92K n/a n/a n/a
Operating Income
-14.54M -11.21M -10.72M -7.91M -3.87M -2.35M -480.04K -256.11K
Interest Income
153.73K 129.94K 55.96K n/a n/a n/a n/a n/a
Pretax Income
-14.41M -11.11M -11.51M -11.45M -7.32M -5.9M -3.29M -366K
Net Income
-14.41M -11.11M -11.51M -11.45M -7.32M -5.9M -3.29M -366K
Selling & General & Admin
9.31M 7.63M 8.44M 6.4M 3.45M 2.1M 261.64K 77.59K
Research & Development
5.18M 3.49M 2.2M 1.46M 390.3K 253.85K 218.41K 178.52K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
14.49M 11.13M 10.64M 7.86M 3.84M 2.35M 480.04K 256.11K
Interest Expense
97.3K 106.27K 106.27K 399.79K 311.55K 431.46K 431.46K 128.87K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-14.54M -11.21M -10.72M -7.91M -3.87M -2.35M -480.04K -256.11K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
12.24M 11.82M 9.51M 8.17M 8.08M 8.08M 8.08M 1.88M
Shares Outstanding (Diluted)
12.24M 11.82M 9.51M 8.17M 8.08M 8.08M 8.08M 1.88M
EPS (Basic)
-1.43 -1.23 -1.36 -1.41 -0.9 -0.87 -0.55 -0.19
EPS (Diluted)
-1.43 -1.23 -1.36 -1.41 -0.9 -0.87 -0.55 -0.19
EBITDA
-14.34M -11M -11.32M -11M -6.98M -5.47M -2.86M -237.13K
EBIT
-14.39M -11.08M -11.4M -11.05M -7.01M -5.47M -2.86M -237.13K
Depreciation & Amortization
52.56K 78.48K 78.48K 51.95K 25.92K n/a n/a n/a